Whole Exome Sequencing Market Key Players Analysis - Thermo Fisher Scientific, Inc.; Illumina, Inc.; Agilent Technologies, Inc.; BGI; Psomagen.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology (synthesis, ion semiconductor sequencing), By Workflow (pre-sequencing, sequencing and data analysis), By Application (Clinical Diagnostics, Drug Discovery & Development, Personalized Medicine), By End-User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies)- Market Outlook And Industry Analysis 2031"

The Global Whole Exome Sequencing Market is estimated to reach over USD 7.30 billion by 2031, exhibiting a CAGR of 20.7% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1770

A genome's whole-exome and protein-coding genes can be sequenced using the exome sequencing technique. Using high-throughput DNA sequencing techniques, the exonic DNA is sequenced after the DNA segments that code for proteins or exons have been chosen. Miller Syndrome and Alzheimer's disease are two illnesses caused by genetic changes that can be found using the exome sequencing approach. The main factors propelling the global whole exome sequencing market are the desire to identify uncommon diseases, the expansion of genomics and next-generation sequencing R&D, and the demand for personalized medication. Global market revenue growth will continue to be fueled by increasing funding in research-based projects, expanding alliances among top companies and research institutions for drug discovery, and a growing preference for next-generation sequencing techniques for diagnosing, treating, and monitoring chronic diseases. New exome sequencing kits, software, and systems are projected to be available over the projection period, and ongoing research on rare illnesses is another factor that will support global market expansion. Additionally, the market's expansion is supported by whole-exome sequencing technology's low cost and quick speed, technological advances in whole-exome sequencing methodology, and strategic alliances among major research institutes worldwide.

List of Prominent Players in the Whole Exome Sequencing Market:
• Thermo Fisher Scientific, Inc
• Illumina, Inc.
• Agilent Technologies, Inc
• BGI
• Psomagen
• Hoffmann-La Roche Ltd
• Azenta US Inc. (GENEWIZ)
• CD Genomics
• Novogene Co, Ltd
• Eurofins Genomics.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:
Drivers-
The primary reasons propelling the worldwide Whole Exome Sequencing Market are the growing applications in clinical diagnostics, increased demand for the detection of uncommon diseases, expanding genomics R&D, next-generation sequencing, and rising need for personalized medicine. The acceptance of next-generation sequencing methods for the diagnosis, prognosis, therapy, and follow-up of numerous chronic diseases, including cancer, is expanding, driving the industry. The acceptance of next-generation sequencing methods for the diagnosis, prognosis, therapy, and follow-up of numerous chronic diseases, including cancer, is expanding, driving the industry.

Challenges:
A lack of qualified professionals, high investment costs, and ethical and legal questions concerning the market's practices and results in various countries are some of the market's challenges. High reliance on government funding is a couple of the issues restricting the growth of the total exome sequencing sector.

Regional Trends:
The North America whole exome sequencing market position is predicted to record a major market share in revenue and is projected to rise at a high CAGR shortly. The main drivers of the growth of the whole-exome sequencing market are the rising prevalence of hereditary and chronic diseases, such as cancer, the increasing demand for personalized and customized medication, and supportive government initiatives. Besides, Asia Pacific had a substantial market share due to the augmented healthcare spending and the increasing prevalence of chronic diseases like diabetes, HIV, and neurological disorders. Favorable government measures for adopting and advancing whole-exome sequencing technology will also boost regional expansion.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1770

Recent Developments:
• In February 2023: According to Illumina Inc., the Broad Institute has just received the company's first NovaSeqX Plus machine. The platform will assist parties wishing to access the company's human whole genome product, blended genome/exome product, and sequencing service.
• In May 2022: Thermo Fisher Scientific and The Qatar Genome Programme (QGP), a Qatar Foundation (QF) division, partnered to advance genomic research and clinical applications of predictive genomics in Qatar as a step towards expanding the advantages of precision medicine to Arab populations.

Segmentation of Whole Exome Sequencing Market-
By Product
• Instruments
• Consumables
• Services
By Technology
• Sequencing by Synthesis
• ION Semiconductor Sequencing
• Others
By Workflow
• Pre-sequencing
• Sequencing
• Data Analysis
By Application
• Clinical Diagnostics
• Drug Discovery & Development
• Personalized Medicine
• Others
By End-use
• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1770

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.